Interchangeable Biosimilars Market Revenue To Hit Usd 65 Billion By 2035, Says Research Nester
Date
9/11/2023 7:17:17 AM
(MENAFN- GlobeNewsWire - Nasdaq) Major Interchangeable Biosimilars market players include Biocon Limited, Mylan N.V., Amgen Inc., CoheBioSciences, Inc., Pfizer Inc., Sandoz International GmbH, Merck & Co., Boehringer Ingelheim group, Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd.,. Major Interchangeable Biosimilars Market players include Biocon Limited, Mylan N.V., Amgen Inc., CoheBioSciences, Inc., Pfizer Inc., Sandoz International GmbH, Merck & Co., Boehringer Ingelheim group, Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd.,.
Tags
Crohnâ€TMs Disease
Ulcerative Colitis
Psoriasis
Diabetes
Cancer
Hematology
Oncology
Autoimmune Disease
Blood Disorder
Related Links
Typhoid Antibody Testing Market Size
Embolization Coils Market Size
Venturi Mask Market Size
Testosterone Injectable Market Size
Non-alcoholic Steatohepatitis (NASH) Treatment Market Size
Prils Market Size
Patient Self-service Kiosk Market Size
Neuroendocrine Tumor Treatment Market Size
Smart Asthma Monitoring Device Market Size
Manufacturing Execution Systems Market Size
Lateral Flow Assays (LFA) Market Size
Medical Device Testing Market Size
Ophthalmoscope Market Size
Drug Delivery Devices Market Size
Cognitive Neuroscience Market Size
MENAFN11092023004107003653ID1107045072
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.